Synageva BioPharma Free Cash Flow:
-14.98M for Dec. 31, 2012Synageva BioPharma Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -14.98M |
| Sept. 30, 2012 | -13.67M |
| June 30, 2012 | -0.228M |
| March 31, 2012 | -6.199M |
| Dec. 31, 2011 | -4.926M |
| Sept. 30, 2011 | -2.964M |
| June 30, 2011 | -5.049M |
| March 31, 2011 | -4.333M |
| Dec. 31, 2010 | -6.832M |
| Sept. 30, 2010 | -2.745M |
| June 30, 2010 | -0.772M |
| March 31, 2010 | -0.787M |
| Dec. 31, 2009 | 12.83M |
| Sept. 30, 2009 | 1.51M |
| June 30, 2009 | 0.916M |
| March 31, 2009 | 1.42M |
| Dec. 31, 2008 | 1.685M |
| Sept. 30, 2008 | 2.31M |
| June 30, 2008 | 3.003M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
GEVA Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Imprimis Pharmaceuticals | -0.6139M |
| Infinity Pharmaceuticals | -36.72M |
| Questcor Pharmaceuticals | 40.89M |
GEVA Free Cash Flow Rankings
| Overall |
53rd percentile 3732 of 8002 |
| Sector |
25th percentile 485 of 650 in Healthcare |
| Industry |
36th percentile 151 of 237 in Biotechnology |
GEVA Free Cash Flow Range, Past 5 Years
| Minimum | -14.98M | Dec 2012 |
| Maximum | 12.83M | Dec 2009 |
| Average | -2.095M |
